Article

AAO releases ROP survey results

The American Academy of Ophthalmology (AAO) released key results from its February 2006 survey on retinopathy of prematurity (ROP).

The American Academy of Ophthalmology (AAO) released key results from its February 2006 survey on retinopathy of prematurity (ROP).

The association surveyed 600 pediatric ophthalmologists and retinal specialists to find out the extent to which the specialists were treating the condition. The response rate was 37% (224 respondents), and the error range at this sample is ±5.5 percentage points at a 90% level of confidence.

The survey found that about half of the specialists currently treat ROP, and about half of the current non-treaters have treated ROP in the past 10 years. Pediatric ophthalmologists had a higher rate of treatment, and about 75% of treating pediatric ophthalmologists and retinal specialists plan to continue treatment.

Those that stopped treatment did so due to concerns about medical liability. Specialists also admitted they may have stopped treatment due to it being outside the physician's area of expertise.

Most physicians felt that ROP is a public health issue (86%), and volunteered suggestions for improving the treatment environment focused on addressing liability issues.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.